AstraZeneca and Oxford University: Confirms immune response in elderly, phase 3 vaccine trial results in weeks

Dhwani Mehta FXStreet

AstraZeneca and Oxford University jointly developed COVID-19 vaccine-induced immune response in older adults in their phase 2 trial, the British drug makers confirmed Thursday.

Additional details

“AstraZeneca phase 2 study does not assess efficacy against COVID-19. “

“Results of phase 3 AstraZeneca vaccine trial expected in weeks.”

Market implications

Amid positive vaccine news coming in from Pfizer and Moderna, with over 90% efficacy in the clinical trials, the latest development from AstraZeneca is quite encouraging.

But it does little to impress to markets, which are unnerved by the growth of covid cases and new shutdowns across the globe.

S&P 500 futures stall its recovery, trading at 3,570, up 0.11% so far.

Author

Dhwani Mehta

FXStreet

Residing in Mumbai (India), Dhwani is a Senior Analyst and Manager of the Asian session at FXStreet. She has over 10 years of experience in analyzing and covering the global financial markets, with specialization in Forex and commodities markets.

GBP/USD strengthens to near 1.3400 as UK political risk fades

The GBP/USD pair gathers strength near 1.3395 during the Asian trading hours on Thursday, bolstered by fading domestic political uncertainty. However, hawkish minutes from the Federal Reserve and renewed tensions between the US and Iran might support the US Dollar and cap the upside for the major pair.

EUR/USD reverses losses, targets 1.1450

EUR/USD trades with decent gains north of the 1.1400 hurdle in the latter part of Wednesday’s NA session. The fresh offered stance in the US Dollar allowed the pair to revert the initial drop and refocus on the upside despite the hawkish tone from the FOMC Minutes and persistent geopolitical tensions.

Gold edges higher on softer USD; remains below $4,100

Gold trades with a positive bias during the Asian session on Thursday and looks to build on the overnight bounce from $4,020, or a one-week low. Minutes of the June FOMC meeting showed an evenly divided debate over the monetary policy outlook and failed to impress the US Dollar bulls, which is seen supporting the bullion. However, fresh US-Iran tensions trigger a sharp recovery in Oil prices, reviving inflationary concerns and reinforcing bets for at least one Fed rate hike in 2026. This should cap the non-yielding yellow metal.

Ethereum: Bulls reclaim dominance, but buying remains weak

Ethereum has slowly seen a return of bullish dominance over the past few days after a lengthy period of bearish pressure. However, buying pressure remains weak despite registering nearly a 10% gain since the beginning of the month.

2.50%: Why the Kiwi's first hike in three years is a wager on a number nobody can see

The Reserve Bank of New Zealand (RBNZ) raised the Official Cash Rate (OCR) by 25 basis points to 2.50% at 02:00 GMT on Wednesday, its first hike in three years and the moment the bank that cut deeper than any G10 peer last cycle turned to face the other way.

Bye, forward guidance: How to trade when central banks choose silence

Central banks have spent years telling markets what might come next. Now, traders face the possibility that they say a lot less. From the Federal Reserve to the European Central Bank and the Bank of England, policymakers are pushing back against forward guidance.